Based on the indirect association between the levels of CP and the stage of fibrosis in CHB patients, we used a combination of biochemical markers and serum CP levels to construct a model and a scoring system to distinguish patients with and without liver cirrhosis. This evidence concerns the gene CP and cirrhosis of liver.